Alle Studien
Aktiv, aber nicht rekrutierendNAINTERVENTIONELL

A Post-market Clinical Follow up of the Genio® System for the Treatment of Obstructive Sleep Apnea in Adults

This study is checking a device called the Genio® system for adults who have a snoring and breathing problem called obstructive sleep apnea (OSA). We want to see over five years if this system is safe and truly helps people with moderate to severe OSA. This is important for those who haven't found other common treatments like breathing machines (CPAP) or mouth guards helpful, or can't use them. The study will follow patients after they have the Genio® system put in, checking their progress at different times for up to five years after their surgery. It's an important step to understand how well this new treatment supports people in the long term.

Auf einen Blick

Status
Aktiv, aber nicht rekrutierend
Phase
NA
Sponsor
Nyxoah S.A.
Einschreibeziel
110
Starten
01 Sep 2019
Geschätzte Fertigstellung
01 Okt 2030

Worum geht es in dieser Studie?

This study is about a medical device called the Genio® system, which is designed to help adults who have a sleep problem called obstructive sleep apnea (OSA). OSA happens when your throat muscles relax too much during sleep, causing your airway to narrow or close, which stops your breathing for short periods. This can lead to loud snoring, feeling tired during the day, and other health issues.

The main goal of this study is to see if the Genio® system is safe and if it truly helps people with moderate to severe OSA breathe better and sleep more soundly. Researchers will be following patients for five years after they have the device fitted to gather this important information. This type of study, called a Post-market Clinical Follow-up, helps us understand how a new treatment performs in real-world conditions over a longer period after it's already available.

This research is particularly important for people who haven't been able to use or benefit from other common treatments for sleep apnea, like Continuous Positive Airway Pressure (CPAP) machines or special mouthguards (mandibular advancement devices). By participating, you would be helping medical science learn more about how to effectively treat OSA for a wider range of patients.

Wichtige Erkenntnisse

  • This study is for adults with moderate to severe obstructive sleep apnea (OSA).
  • It's looking at the Genio® system as a long-term treatment option.
  • The study follows patients for 5 years after surgery.
  • It's for people who haven't had success with other OSA treatments.
  • The main goals are to check the device's safety and how well it works.
  • Participation involves surgery and regular follow-up visits and phone calls.

Wer könnte berechtigt sein?

To join this study, adults must be 18 years or older. You should have moderate to severe obstructive sleep apnea (OSA), confirmed by a sleep study, where your breathing stopping and starting happens between 15 and 65 times per hour. You also need to have tried other common treatments for OSA, like a CPAP machine or a mouthguard, and found they didn't work for you, you couldn't tolerate them, or you chose not to use them. Your body mass index (BMI) – a measure of weight to height – should also be below 35.

There are some reasons why you might not be able to join. For example, if you have other untreated sleep problems that aren't OSA, or if you're taking medicines that might affect your consciousness or breathing during sleep. Major physical issues in your throat or mouth that could stop the Genio® system from working properly, or untreated mental health conditions that might make it hard to follow the study's requirements, would also mean you couldn't take part.

Additionally, if you have a life expectancy of less than 12 months, or are already involved in another clinical study right now (unless it's just a registry), you wouldn't be able to participate in this one.

Könnte diese Studie für Sie geeignet sein?

Beantworten Sie diese kurzen Fragen, um zu sehen, ob Sie möglicherweise berechtigt sind. Dies ist nur ein Leitfaden – das Forschungsteam trifft die endgültige Entscheidung.

  1. Sind Sie 18 Jahre alt oder älter?
  2. Do you have moderate to severe obstructive sleep apnea (OSA)?
  3. Have other OSA treatments (like CPAP or a mouthguard) not worked for you?
  4. Is your Body Mass Index (BMI) below 35?
  5. Do you have any other untreated serious sleep, mental health, or breathing problems?
Beantworten Sie jede Frage, um Ihr Ergebnis zu sehen.

Was beinhaltet die Teilnahme?

If you join this study, you will have the Genio® system fitted through a surgical procedure. After your surgery, the device will be switched on between 6 to 10 weeks later. You will then have several follow-up appointments at the clinic: at 3 months, 6 months, 9 months, and 12 months after the device is activated. After the first year, you will have yearly check-ups at the clinic for a total of 5 years following your surgery.

In between some of the clinic visits, specifically at 18 months, 30 months, 42 months, and 54 months, a member of the study team will contact you by phone to check in on your progress and well-being. Throughout these five years, the study team will be carefully monitoring the safety and how well the Genio® system is working for you. There is no mention of specific medications given as part of this study, but your usual medications will be reviewed.

Potenzielle Risiken und Vorteile

Taking part in any medical study has potential benefits and risks. The potential benefit of joining this study is that the Genio® system might help improve your obstructive sleep apnea, potentially leading to better sleep and overall health, especially if other treatments haven't worked for you. However, as with any surgery, there are risks involved, including the risks associated with the operation itself and the possibility of side effects from the device. The study is designed to carefully monitor for any safety concerns and how well the device works. You have the right to withdraw from the study at any time, for any reason, without it affecting your usual medical care.

Locations (19)

  • Ziekenhuis Netwerk Antwerpen - ZNA Jan Palfijn
    Verifizierte Postleitzahl
    Antwerp, Belgium
  • Universitair Ziekenhuis Antwerpen
    Verifizierte Postleitzahl
    Antwerp, Belgium
  • CHU - Angers
    Verifizierte Postleitzahl
    Angers, Frankreich
  • Hôpital Henri-Mondor AP-HP
    Verifizierte Postleitzahl
    Créteil, France
  • Hôpital Privé La Louvière
    Verifizierte Postleitzahl
    Lille, Frankreich
  • Clinique Beau-Soleil
    Verifizierte Postleitzahl
    Montpellier, Frankreich
  • Hôpital Bichat, Assistance Publique - Hôpitaux de Paris
    Verifizierte Postleitzahl
    Paris, Frankreich
  • CEREVES Paris Jean Jaurès - Centre du sommeil
    Verifizierte Postleitzahl
    Paris, Frankreich
  • Hôpital Tenon AP-HP
    Verifizierte Postleitzahl
    Paris, Frankreich
  • Clinique Mutualiste de la Sagesse
    Verifizierte Postleitzahl
    Rennes, France
  • Polyclinique Saint Laurent
    Verifizierte Postleitzahl
    Rennes, France
  • CHU Toulouse
    Verifizierte Postleitzahl
    Toulouse, Frankreich

Häufige Fragen

What is obstructive sleep apnea (OSA)?

OSA is a common condition where your breathing repeatedly stops and starts while you sleep because your throat muscles relax too much and block your airway.

What is the Genio® system?

The Genio® system is a medical device designed to help adults with OSA. This study is looking at how safe and effective it is over the long term.

Wie lange werde ich an der Studie teilnehmen?

If you join, you will be followed for a full 5 years after your surgery to have the Genio® system fitted.

What if I've tried other sleep apnea treatments?

This study is specifically for people who couldn't use, didn't tolerate, or found that other treatments like CPAP machines or mouthguards didn't work for them.

Kann ich die Studie verlassen, wenn ich meine Meinung ändere?

Yes, you are free to stop participating in the study at any time, for any reason, without it affecting your medical care.

Wie Sie mehr erfahren können

Sprechen Sie immer mit Ihrem Hausarzt oder Spezialisten, bevor Sie sich entscheiden, an einer Studie teilzunehmen.

Diskussion

Community-Diskussion

Bereitgestellt von unserem Forum bei community.patient.info. Bitte seien Sie respektvoll — dies ist kein medizinischer Rat.